The Blood and Marrow Transplant Program is conducted in conjunction with the Rutgers Cancer Institute of New Jersey.
The Blood and Marrow Transplant team performs stem cell transplants
for patients with a variety of illnesses, including acute and chronic
leukemias, myelodysplasia, various types of lymphoma, Hodgkin's disease,
multiple myeloma, amyloidosis and related diseases. Both autologous
and allogeneic transplants are performed.
The sources of transplant include matched siblings as well as matched
unrelated donors and umbilical cord blood. There are several research
initiatives within the Blood and Marrow Transplant program. In
addition to participating in national and international clinical
research studies with other transplant centers, there are unique
research programs focusing on novel ways to: prevent graft-versus-host
disease; improve umbilical cord blood transplants; and develop novel
cellular therapies with less toxicity than standard transplants. The
program is certified by FACT as well as the National Marrow Donor Program.